scholarly journals Ventilator flow data predict bronchopulmonary dysplasia in extremely premature neonates

2018 ◽  
Vol 4 (1) ◽  
pp. 00099-2017 ◽  
Author(s):  
Mariann H. Bentsen ◽  
Trond Markestad ◽  
Thomas Halvorsen

Early prediction of bronchopulmonary dysplasia (BPD) may facilitate tailored management for neonates at risk. We investigated whether easily accessible flow data from a mechanical ventilator can predict BPD in neonates born extremely premature (EP).In a prospective population-based study of EP-born neonates, flow data were obtained from the ventilator during the first 48 h of life. Data were logged for >10 min and then converted to flow–volume loops using custom-made software. Tidal breathing parameters were calculated and averaged from ≥200 breath cycles, and data were compared between those who later developed moderate/severe and no/mild BPD.Of 33 neonates, 18 developed moderate/severe and 15 no/mild BPD. The groups did not differ in gestational age, surfactant treatment or ventilator settings. The infants who developed moderate/severe BPD had evidence of less airflow obstruction, significantly so for tidal expiratory flow at 50% of tidal expiratory volume (TEF50) expressed as a ratio of peak tidal expiratory flow (PTEF) (p=0.007). A compound model estimated by multiple logistic regression incorporating TEF50/PTEF, birthweight z-score and sex predicted moderate/severe BPD with good accuracy (area under the curve 0.893, 95% CI 0.735–0.973).This study suggests that flow data obtained from ventilators during the first hours of life may predict later BPD in premature neonates. Future and larger studies are needed to validate these findings and to determine their clinical usefulness.

2016 ◽  
Vol 33 (S1) ◽  
pp. S77-S78
Author(s):  
S. Ouanes ◽  
E. Castelao ◽  
A. Von Gunten ◽  
M. Preisig ◽  
J. Popp

BackgroundOlder people are particularly exposed to stressful events, known to activate the hypothalamus-pituitary-adrenal axis. Many studies highlighted the possible deleterious effects of elevated cortisol on cognition, assuming a likely role of stressful events. Yet, very few studies actually examined these assumed links between life events, cortisol and cognition.ObjectiveTo examine associations between salivary cortisol, cognition and life events in a population of non-demented old individuals.MethodsA cross-sectional analysis was conducted using data from Colaus/PsyColaus, a longitudinal population-based study involving 6733 Lausanne residents. Salivary cortisol samples (upon waking, 30 minutes after waking, at 11 am and at 8 pm) were obtained from 799 non-demented participants aged at least 60.Life events, activities of daily life along with depressive symptoms were assessed using a standardized questionnaire. A comprehensive neuropsychological test battery was used to determine the Clinical Dementia Rating (CDR).For multiple comparisons, P values were adjusted (P′) according to Holm-Bonferroni's method.ResultsCortisol at 11 am and cortisol area under the curve (AUC) were positively correlated with CDR sum of boxes (CDRSOB) scores (P′ = 0.035; Rho = 0.097 and P′ = 0.024; Rho = 0.110, respectively). The association between cortisol AUC and CDRSOB remained significant after controlling for age, sex, body mass index, education, smoking and depression (P = 0.001; β = 0.001; R2 change = 0.016).The number and the total impact of life events were associated neither with cortisol nor with CDRSOB.ConclusionsElevated cortisol was associated with poorer cognitive functioning yet independently of life events. This suggests that the increased cortisol associated with poorer cognition might be not a mere reflection of stressful events but rather explained by other factors, yet to be elucidated.Disclosure of interestThe authors have not supplied their declaration of competing interest.


PLoS ONE ◽  
2013 ◽  
Vol 8 (9) ◽  
pp. e75168 ◽  
Author(s):  
Ting-An Yen ◽  
Hwai-I Yang ◽  
Wu-Shiun Hsieh ◽  
Hung-Chieh Chou ◽  
Chien-Yi Chen ◽  
...  

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Sara Schramm ◽  
Martha Jokisch ◽  
Karl-Heinz Jöckel ◽  
Arne Herring ◽  
Kathy Keyvani

Abstract Background Kallikrein-8 (KLK8) might be an early blood-biomarker of Alzheimer’s disease (AD). We examined whether blood KLK8 is elevated in persons with amnestic mild cognitive impairment (aMCI) which is a precursor of AD, compared to cognitively unimpaired (CU) controls. Methods Forty cases and 80 controls, matched by sex and age (± 3years), were participants of the longitudinal population-based Heinz Nixdorf Recall study (baseline: 2000–2003). Standardized cognitive performance was assessed 5 (T1) and 10 years after baseline (T2). Cases were CU at T1 and had incidental aMCI at T2. Controls were CU at T1 and T2. Blood KLK8 was measured at T2. Using multiple logistic regression the association between KLK8 in cases vs. controls was investigated by estimating odds ratios (OR) and 95% confidence intervals (95%CI), adjusted for inter-assay variability and freezing duration. Using receiver operating characteristic (ROC) analysis, the diagnostic accuracy of KLK8 was determined by estimating the area under the curve (AUC) and 95%CI (adjusted for inter-assay variability, freezing duration, age, sex). Results Thirty-seven participants with aMCI vs. 72 CU (36.7%women, 71.0±8.0 (mean±SD) years) had valid KLK8 measurements. Mean KLK8 was higher in cases than in controls (911.6±619.8 pg/ml vs.783.1±633.0 pg/ml). Fully adjusted, a KLK8 increase of 500pg/ml was associated with a 2.68 (1.05–6.84) higher chance of having aMCI compared to being CU. With an AUC of 0.92 (0.86–0.97), blood KLK8 was a strong discriminator for aMCI and CU. Conclusion This is the first population-based study to demonstrate the potential clinical utility of blood KLK8 as a biomarker for incipient AD.


2020 ◽  
Vol 135 ◽  
pp. 110941
Author(s):  
Caterina Trevisan ◽  
Debora Rizzuto ◽  
Giuseppe Sergi ◽  
Stefania Maggi ◽  
Anna-Karin Welmer ◽  
...  

2007 ◽  
Vol 53 (5) ◽  
pp. 963-970 ◽  
Author(s):  
Robert Clarke ◽  
Paul Sherliker ◽  
Harold Hin ◽  
Ebba Nexo ◽  
Anne Mette Hvas ◽  
...  

Abstract Background: Impaired vitamin B12 function and decreased vitamin B12 status have been associated with neurological and cognitive impairment. Current assays analyze total vitamin B12 concentration, only a small percentage of which is metabolically active. Concentrations of this active component, carried on holotranscobalamin (holoTC), may be of greater relevance than total vitamin B12. Methods: We compared the utility of serum holoTC with conventional vitamin B12 for detection of vitamin B12 deficiency in a population-based study of older people, using increased methylmalonic acid (MMA) concentrations as a marker of metabolic vitamin B12 deficiency in the overall population (n = 2403) and in subsets with normal (n = 1651) and abnormal (n = 752) renal function. Results: Among all participants, 6% had definite (MMA >0.75 μmol/L) and 16% had probable (MMA >0.45 μmol/L) metabolic vitamin B12 deficiency. In receiver operating characteristic curves for detection of definite vitamin B12 deficiency, holoTC had a greater area under the curve (AUC) compared with vitamin B12 in all participants (0.85 vs 0.76; P <0.001) and in subsets with normal (AUC: 0.87 vs 0.79; P <0.001) and abnormal (AUC: 0.85 vs 0.74; P = 0.002) renal function. Similar findings were observed for detection of moderate vitamin B12 deficiency. Whereas the positive predictive value for both holoTC and vitamin B12 was greater for detection of probable than definite vitamin B12 deficiency, both tests were associated with more false-positive than true-positive test results. Conclusions: HoloTC has a modestly superior diagnostic accuracy compared with conventional vitamin B12 for the detection of vitamin B12 deficiency, but neither test can be recommended to screen asymptomatic populations.


2021 ◽  
Author(s):  
Elisabeth B. Budal ◽  
Cathrine Ebbing ◽  
Jørg Kessler ◽  
Sukhjeet Bains ◽  
Olav H. Haugen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document